News from the healthcare data industry
Seasoned leader will oversee expanding solutions to support clinicians in providing the best possible patient care Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care...
April 10, 2024 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced...
The American Cancer Society (ACS) and Flatiron Health announced the recipients of the 2023 Real-World Data Impact Awards, which will support clinically relevant research regarding the treatment of and outcomes...
March 13, 2024 08:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology and closing...
The combined power from Caris’ DNA, RNA and imaging data with Flatiron’s world-classclinical data establishes a powerful multimodal dataset to drive next-gen therapeutic development and advance patient care IRVING, Texas, Jan....
November 13, 2023 Flatiron Health today announced that the company will present a total of six abstracts accepted for oral and poster presentation at this year’s American Society of Hematology...
October 31, 2023 08:05 AM Eastern Daylight Time PALO ALTO, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Flatiron Health, a leading healthtech company...
October 23, 2023 Flatiron Health today announced a new agreement to bring Flatiron Assist™ advanced cancer care insights to oncology care clinicians at Penn Medicine’s Abramson Cancer Center (ACC). The collaboration...
October 23, 2023 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced a new agreement to bring Flatiron Assist™ advanced cancer care insights to oncology care clinicians at Penn...
October 2, 2023 In today’s rapidly evolving landscape of accelerated drug development, reliance solely on data derived from traditional randomized control trials (RCTs) is shifting toward a combination of RCT...